Introduction: The renin-angiotensin system (RAS) has been considered to play an important role in the regulation of blood pressure. This study aimed to investigate the correlation between RAS gene polymorphisms and essential hypertension (EH) in the Chinese Yi ethnic group. Materials and methods: A total of 244 EH subjects and 185 normotensive individuals from the Chinese Yi ethnic group were genotyped for AGT M235T (rs699), AT1R A1166C (rs5186), ACE I/D (rs4340) and ACE G2350A (rs4343) polymorphisms by the polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) method. Results: Significant differences in the allele and genotype frequency of ACE G2350A were observed between the EH cases and controls (p=0.001, 0.002). After being grouped by gender, significant differences in the allele and genotype frequency of ACE G2350A and AT1R A1166C were observed between females of the EH cases and controls (ACE G2350A: p=0.000, 0.002; AT1R A1166C: p=0.008, 0.011). After excluding the influence of multifactorial interactions, the ACE G2350A polymorphism is significantly associated with the pathogenesis of EH in the Chinese Yi ethnic group (odds ratio (OR)=1.656, 95% confidence interval (CI) 1.807-2.524, p=0.019). Conclusions: The RAS-related ACE G2350A polymorphism is associated with the pathogenesis of EH in the Chinese Yi ethnic group.
Introduction
Hypertension is a common disease that affects approximately 22% of the world's population. 1 There are hundreds of millions of hypertension patients in China currently, and the vast majority of these patients have essential hypertension (EH). The prevalence of hypertension is quite different among the various ethnic groups in China. The most recent World Health Organization reported that the prevalence of hypertension was 19.8% in Chinese adults aged 18 years and over. 1 In contrast, the prevalence of hypertension in the rural Yi ethnic group, which has a lower morbidity rate, was only 3.19%. 2 In addition to the differences in geographical distribution, living habits, economy and culture among different ethnic groups, the differences in genetic background may be the major factor affects the prevalence of EH. This study focused on the Yi ethnic group to provide valuable information on the genetic mechanism of EH.
The etiology of EH has attracted the attention of the researchers in recent years and nearly 150 candidate genes have been studied. Of these genes, the renin-angiotensin system (RAS) has been considered to play an important role in the regulation of blood pressure, the maintenance of salt and water balance and the remodeling of cardiovascular tissue. 3 In this system, the angiotensinogen (AGT) gene, the angiotensin II type 1 receptor (AT1R) gene and the angiotensin-converting enzyme (ACE) gene are considered to be important candidate genes for EH. Previous studies found that polymorphisms in RAS genes (i.e. AGT M235T (rs699), AT1R A1166C (rs5186), ACE I/D (rs4340), and ACE G2350A (rs4343)) were associated with the pathogenesis of EH. [4] [5] [6] [7] However, the results of the studies that investigated different populations were not consistent. [8] [9] [10] [11] We conducted a case-control study that included 244 EH subjects and 185 normotensive individuals from the Chinese Yi ethnic group. The correlations between the RAS-related AGT M235T, AT1R A1166C, ACE I/D, ACE G2350A polymorphisms and EH were investigated comprehensively and systematically in the Chinese Yi ethnic group. The present study will help elucidate the genetic mechanism of EH and facilitate the prevention and early diagnosis of EH.
Materials and methods

Study subjects
This study was approved by the ethics committee of Kunming Medical University. All of the tested individuals gave informed consent for this survey and examinations. All subjects in the study were from the Shuanghe Yi Village, which is in Jinning County, Kunming Prefecture, Yunnan Province, China. All subjects were local Yi. Due to the backward economy and the inconvenience of communication in this region, this village has a relatively isolated population with a homogenous genetic background. The right arm blood pressure was measured three times with a mercury sphygmomanometer in a sitting position; the mean of three readings was used for the statistical analysis. Hypertension was defined as systolic blood pressure ⩾140 mm Hg or diastolic blood pressure ⩾90 mm Hg (1 mm Hg=0.133 kPa) or the use of antihypertensive medication during the previous two weeks. Subjects with secondary hypertension, diabetes, liver and kidney dysfunction, coronary heart disease, and other cardiovascular disorders were excluded. The normotensive controls had a systolic blood pressure <140 mm Hg and a diastolic blood pressure <90 mm Hg. Subjects with a history of hypertension, diabetes, or liver, kidney and heart disease were excluded from this group.
Determination indicators and methods
For all subjects, disease history was collected; meanwhile, systolic blood pressure, diastolic blood pressure, height, weight, and waist and hip circumference were measured.
Also measured were the body mass index (BMI)=weight/ height 2 (kg/m 2 ) and the waist-hip ratio (WHR)=waist circumference (cm)/hip circumference (cm). Smoking and drinking habits of participants were surveyed. Fasting venous blood was collected from each of the tested individuals to examine liver and kidney function, total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), triglycerides (TG), serum uric acid (SUA) and other parameters.
Genomic DNA extraction
A volume of 2 ml of venous blood was collected from all the subjects in ethylene diamine tetraacetic acid (EDTA) tubes. Then leukapheresis was performed. After hemolysis with hypotonic solution, genomic DNA was isolated by phenolchloroform extraction. The genomic DNA was dissolved in TE buffer (Tris-EDTA buffer) and stored at 4°C.
Polymorphism analysis
AGT M235T. The polymerase chain reaction (PCR)restriction fragment length polymorphism (RFLP) method was used for polymorphism analysis. For primer sequences, PCR reaction conditions, restriction enzymes and digestion conditions, please see the relevant report by Ishigami et al. 12 The PCR product was 163 bp, and two fragments of 140 bp and 23 bp were generated after restriction digestion, but only the 140 bp fragment was revealed in electrophoresis. If no mutation was present at this site, then the amplified fragment length would not change. There are two alleles for this polymorphism site: allele M (163 bp) and allele T (140 bp).
AT1R A1166C. The PCR-RFLP method was used for polymorphism analysis. For primer sequences, PCR reaction conditions, restriction enzymes and digestion conditions, please see the relevant report by Katsuya et al. 13 The amplified PCR product was 360 bp, and two fragments of 220 bp and 140 bp were generated after restriction digestion. If no mutations were present at this site, then the amplified fragment length would not change. There are two alleles for this polymorphism site: allele A (360 bp) and allele C (140 bp and 220 bp). ACE G2350A. The PCR-RFLP method was used for polymorphism analysis. For primer sequences, PCR reaction conditions, restriction enzymes and digestion conditions, please see the relevant report by Vasudevan et al. 15 The amplified PCR product was 122 bp, and two fragments of 100 bp and 22 bp were generated after restriction digestion. But only the 100 bp fragment was revealed in electrophoresis. If no mutations were present at this site, the amplified fragment length would not change. There are two alleles for this polymorphism site: allele G (122 bp) and allele A (100 bp).
Statistical analysis
SHEsis software was used for the Hardy-Weinberg equilibrium test and the chi-square test of the genotype and allele frequencies. 16 PLINK software was used for genotype dominant and recessive mode analysis for all four sites. SPSS16.0 software was used for the logistic regression analysis of the multifactorial interaction influence, and the odds ratio (OR) value and 95% confidence interval (CI) were calculated. Continuous variables were represented as means±standard deviation (SD). Student's t test was used to compare measured data between groups. The χ 2 test was used to compare counted data between groups. PS software was used for conclusion accuracy analysis. 17
Results
The present study included a total of 244 EH patients (92 males, 152 females) and 185 normotensive controls (70 males, 115 females). The average age of the EH group was 59.281±12.828 years, and the average age of the control group was 61.148±13.491 years. A comparison of the clinical and biochemical parameters is presented in Table 1 . The BMI, WHR, TC, LDL-C, TG and SUA values and the smoking and alcohol consumption proportions of the EH group were significantly higher than those of the control group (p<0. 05).
Analysis revealed that the genotype distribution of the four studied polymorphisms was consistent with Hardy-Weinberg equilibrium in both the EH and control groups.
ACE G2350A polymorphism
The A allele frequencies of the EH group and the control group were 29.1% and 19.5%, respectively; the difference between these values was statistically significant (χ 2 =10.444, p=0.001). The AA, GA and GG genotype frequencies of the EH group and the control group were 10.7%, 36.9%, 52.5% and 5.9%, 27.0%, 67.0%, respectively; this difference also reached statistical significance (χ 2 =9.641, p=0.008). After being grouped by gender, the A allele frequencies among females in the EH group and the control group were 28.6% and 15.7%, respectively. The AA, GA and GG genotype frequencies were 10.5%, 36.2%, 53.3% and 3.5%, 24.3%, 72.2%, respectively. All of these differences were statistically significant (χ 2 =12.417, p=0.000; χ 2 =11.093, p=0.004). The A allele, which has a lower frequency in the population, is assumed to be a mutant gene. Under dominant mode, individuals carrying this mutation are more susceptible to EH (AA+GA vs GG, p=0.002). Under recessive mode, the difference is not significant (AA vs AG+GG). Therefore, we propose that if the A allele is associated with the pathogenesis of EH, it may function in dominant mode. In males, neither the allele frequency nor the genotype frequency of this site exhibited a significant difference between the two groups ( Table 2 and Table 3 ).
AT1R A1166C polymorphism
No significant differences in the allele frequency and genotype frequency were observed between the two groups. After being grouped by gender, however, the C allele frequency among females in the EH group was higher than that of the control group (4.9% and 0.9%, respectively). This difference was statistically significant (χ 2 =7.019, p=0.008). The CC, AC and AA gene frequencies of the EH group and the control group were 0.7%, 8.6%, 90.8% and 0%, 1.7%, 98.3%, respectively (χ 2 =6.555, p=0.038). The C allele, which has a lower frequency in the population, is assumed to be a mutant gene. Under dominant mode, individuals carrying this mutation are more susceptible to EH (CC+AC vs AA, p=0.011). Under recessive mode, this difference is not significant (CC vs AC+AA). Therefore, we suggest that if the C allele is associated with the pathogenesis of EH, it may function in dominant mode. Among females, the p value for the comparison of the genotype frequency of this site between the two groups was slightly higher than the corrected critical value (Bonferroni correction p=0.013); however, under dominant mode, the p value was smaller than this critical value. Therefore, we suggest that among Yi females, a significant difference in the genotype frequency of this site exists between the EH group and the control group. In contrast, among males, neither the allele frequency nor the genotype frequency of this site exhibited a significant difference between the two groups ( Table 2 and Table 3 ).
AGT M235T polymorphism
No significant differences in allele frequency or genotype frequency were observed between the two groups. No significant differences in allele frequency or genotype frequency were observed between the two groups among individuals of either gender ( Table 2 and Table 3 ).
ACE I/D polymorphism
Genetic power test
We performed a study with 488 experimental subjects and 370 control subjects. The probability of exposure among controls is 0.195. If the true probability of exposure among cases is 0.291, we will be able to reject the null hypothesis that the exposure rates for case and controls are equal with probability (power) 0.901. The Type I error probability associated with this test of this null hypothesis is 0.05. We used an uncorrected chi-squared statistic to evaluate this null hypothesis.
Multivariate logistic regression analysis
We used BMI, WHR, TC, HDL-C, LDL-C, TG, SUA, drinking, smoking and ACE G2350A (AA+GA vs GG), AT1R A1166C (CC+AC vs AA), which exhibited differences in the univariate analysis, as the independent variables and EH as the dependent variable to perform a multivariate logistic regression analysis. The results demonstrated that under the influence of multifactorial interactions, the genetic factor that had a significant impact on the pathogenesis of EH in the Yi ethnic group was the ACE G2350A polymorphism. The risk of being affected by EH for individuals with a genotype of AA/GA was 1.656 times higher than that of individuals with a genotype of GG (OR=1.656, 95% CI 
Discussion
ACE is an important component of the RAS because this enzyme can convert angiotensin I (Ang I) to angiotensin II (Ang II), which exhibits a strong vasoconstrictor activity. 18 The G2350A (rs4343) polymorphism, which is located in an exon, is related to the plasma ACE concentration. 19 ACE can increase vascular tension and increase blood pressure through Ang II. 20 A study of the Emirati population in 2003 demonstrated that the G2350A polymorphism could increase the risk of EH. 21 Subsequent studies in south Indian, Malaysia and Pakistan also found that the polymorphism at this site was associated with blood pressure variability and EH. 15, 22, 23 Studies in the Chinese Han population demonstrated that the polymorphism at this site was not associated with EH. 24 To date, no reports on the correlation between the polymorphism at this site and EH are available for other Chinese ethnic groups. Our study found significant association of ACE G2350A polymorphism with EH in the Chinese Yi ethnic group and that the 2350A allele can increase the risk of EH. The present study demonstrates that the 2350A allele frequency of EH patients in the Yi ethnic group is 0.291, which is slightly higher than that of the Pakistani population (0.226) 23 and similar to those of the Indian, Malaysian and Emirati populations (0.342, 0.343, and 0.258, respectively). 9, 15, 21 This frequency is significantly lower than that of the Chinese Han population (0.550). 25 Ang II in the RAS increases blood pressure by binding to its receptor (i.e. angiotensin II receptor (ATR)). AT1R A1166C was one of the first polymorphic loci to be associated with EH. 7 Subsequently, a large number of related studies were conducted in different populations; however, the results were inconsistent. [26] [27] [28] The results of our study demonstrated that no significant differences in the AT1R A1166C polymorphism existed between the EH group and the control group. However, after we grouped the patients by gender, among females, significant differences in both the allele frequency and the genotype frequency of this site were observed between the EH group and the control group, indicating the association of A1166C polymorphism with the occurrence of EH in Yi females. A possible explanation for this finding is that the A1166C polymorphism affects the binding between AT1R and Ang II, thereby affecting the ability of Ang II to act as a vasoconstrictor and increase blood pressure. Thus, this effect changes the risk of EH occurrence. Based on our study, the 1166C allele frequency in the Yi ethnic group is 0.045, which is similar to that of the Taiwanese population (0.038) 29 and lower than those of the Japanese (0.087), 30 Caucasian (0.398) 31 and Ukrainian (0.513) 26 populations.
It is worth noting that in our results, after being grouped by gender, the ACE G2350A and AT1R A1166C polymorphisms were associated with the occurrence of EH in females but not in males. Studies in south Indian also demonstrated the existence of gender-based differences in RAS gene polymorphism. 32 This difference may occur due to the regulation of RAS activity by estrogen and variations in the sensitivity of different alleles to estrogen. Clinically, the prevalence of hypertension in post-menopausal females was found to be much higher than that of pre-menopausal females; estrogen deficiency was the main reason for this difference. Estrogen can reduce the conversion of Ang I to Ang II by reducing ACE activity. Estrogen can also reduce the expression and concentration of AT1R, thereby affecting the RAS. 33 In addition, previous studies revealed the existence of gender-based differences in the regulation of pulse pressure by the RAS; in different sexes, different pathways were used by the RAS to increase or decrease blood pressure. 34 This finding suggests that the gender-based differences in the RAS may be related to the regulation of blood pressure and the pathogenesis of hypertension.
We mentioned above that the Yi ethnic group had a lower EH prevalence than other Chinese ethnic groups; the prevalence of EH in this group was much lower than the national average. Multivariate analysis revealed that among the four polymorphic sites studied here, only the ACE G2350A polymorphism was associated with EH occurrence in the Yi ethnic group. We speculate that the Yi ethnic group carries less pathogenic genes for EH, leading to a lower EH prevalence and the detection of a smaller proportion of positive sites in our study.
The comparison of clinical and biochemical parameters revealed significant differences in TG and SUA between the EH group and the control group, indicating that dyslipidemia and increased SUA may affect blood pressure in the Yi ethnic group to a certain degree. A number of studies demonstrated that different components of the RAS were up-regulated in hypertension and atherosclerosis patients. In addition, the accumulation of lipids in the blood vessels can enhance the expression of RAS components. 35 Recent studies revealed that SUA is strongly associated with blood pressure in new and recent onset essential hypertension. The UA may play a role in the pathogenesis of hypertension. 36 The mechanism by which SUA increases blood pressure remains unclear. High levels of SUA may activate the RAS or induce high SUArelated insulin resistance, then lead to high blood pressure.
It is noted that the sample size in our study is small, although the probability (power) of the chi-squared test is 0.901. However, we believe that the positive associations which we observed in our survey are convincing. Because the samples came from a genetic similar or genetically homogeneous population, the disease gene spectrum of hypertension may be narrow in this population. A few disease gene mutations responded for the hypertension in Yi people. So the statistical power is still high. Further surveys with a larger sample size and through the whole gene will be valuable for confirming these positive associations and finding the functional mutations which could potentially link with these positive associations.
